SPAC Overview
Timeline Progress
About
BioPlus Acquisition Corp. is a newly incorporated blank-check company seeking a business combination, with its search focused on the life sciences industry. It excludes a target whose principal business operations are in China, including Hong Kong and Macau.
Investment Focus
Biopharmaceuticals
The terms and the filing trail behind BioPlus Acquisition Corp.
What the sponsor registered, what the deal actually priced at, and every 8-K that moved it — unit structure, sponsor promote, and the dated lifecycle events, each linked to its filing.
- Unit structure as registered and as priced — price, warrant coverage, rights, trust per unit
- Sponsor promote: founder shares and percentage, private-placement warrants, trust deposit
- The full 8-K lifecycle timeline, each event linked to its filing
- Price history across the unit, share and warrant tickers
- Follow it, and see it change on your watchlist
SPAC Team
Sponsors
Leadership
Underwriters
Extended Team Information
The leadership team is led by Jonathan Rigby, a biotechnology and pharmaceutical company executive, and Ross Haghighat, a technology entrepreneur and venture capitalist. The directors and nominees bring experience in biotechnology and life sciences operations, investing, healthcare, finance and governance.